This invention is directed to compounds of formula (I): where, n, m, Y, Rl, R2, R3, R4 and R5 are disclosed herein, as isolated stereoisomers or mixtures thereof, or as pharmaceutically acceptable salts thereof pharmaceutical compositions comprising the compounds of formula (I) and methods of using the compounds and the pharmaceutical compositions in treating diseases or conditions associated with JAK2 activity